IBDEI32J ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48998,1,3,0)
 ;;=3^Observation/Exam,Unspec Reason
 ;;^UTILITY(U,$J,358.3,48998,1,4,0)
 ;;=4^Z04.9
 ;;^UTILITY(U,$J,358.3,48998,2)
 ;;=^5062666
 ;;^UTILITY(U,$J,358.3,48999,0)
 ;;=Z51.5^^185^2428^94
 ;;^UTILITY(U,$J,358.3,48999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48999,1,3,0)
 ;;=3^Palliative Care Encounter
 ;;^UTILITY(U,$J,358.3,48999,1,4,0)
 ;;=4^Z51.5
 ;;^UTILITY(U,$J,358.3,48999,2)
 ;;=^5063063
 ;;^UTILITY(U,$J,358.3,49000,0)
 ;;=Z12.9^^185^2428^162
 ;;^UTILITY(U,$J,358.3,49000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49000,1,3,0)
 ;;=3^Screening for Malig Neop,Unspec Site
 ;;^UTILITY(U,$J,358.3,49000,1,4,0)
 ;;=4^Z12.9
 ;;^UTILITY(U,$J,358.3,49000,2)
 ;;=^5062698
 ;;^UTILITY(U,$J,358.3,49001,0)
 ;;=Z13.9^^185^2428^163
 ;;^UTILITY(U,$J,358.3,49001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49001,1,3,0)
 ;;=3^Screening,Unspec
 ;;^UTILITY(U,$J,358.3,49001,1,4,0)
 ;;=4^Z13.9
 ;;^UTILITY(U,$J,358.3,49001,2)
 ;;=^5062721
 ;;^UTILITY(U,$J,358.3,49002,0)
 ;;=Z48.89^^185^2428^164
 ;;^UTILITY(U,$J,358.3,49002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49002,1,3,0)
 ;;=3^Surgical Aftercare Encounter,Other Spec
 ;;^UTILITY(U,$J,358.3,49002,1,4,0)
 ;;=4^Z48.89
 ;;^UTILITY(U,$J,358.3,49002,2)
 ;;=^5063055
 ;;^UTILITY(U,$J,358.3,49003,0)
 ;;=Z51.81^^185^2428^167
 ;;^UTILITY(U,$J,358.3,49003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49003,1,3,0)
 ;;=3^Therapeutic Drug Level Monitoring
 ;;^UTILITY(U,$J,358.3,49003,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,49003,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,49004,0)
 ;;=Z77.9^^185^2428^55
 ;;^UTILITY(U,$J,358.3,49004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49004,1,3,0)
 ;;=3^Exposures/Contact with Hazardous Substances
 ;;^UTILITY(U,$J,358.3,49004,1,4,0)
 ;;=4^Z77.9
 ;;^UTILITY(U,$J,358.3,49004,2)
 ;;=^5063326
 ;;^UTILITY(U,$J,358.3,49005,0)
 ;;=R50.9^^185^2428^57
 ;;^UTILITY(U,$J,358.3,49005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49005,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,49005,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,49005,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,49006,0)
 ;;=Z96.9^^185^2428^58
 ;;^UTILITY(U,$J,358.3,49006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49006,1,3,0)
 ;;=3^Functional Implant,Unspec
 ;;^UTILITY(U,$J,358.3,49006,1,4,0)
 ;;=4^Z96.9
 ;;^UTILITY(U,$J,358.3,49006,2)
 ;;=^5063719
 ;;^UTILITY(U,$J,358.3,49007,0)
 ;;=Z72.6^^185^2428^59
 ;;^UTILITY(U,$J,358.3,49007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49007,1,3,0)
 ;;=3^Gambling and Betting
 ;;^UTILITY(U,$J,358.3,49007,1,4,0)
 ;;=4^Z72.6
 ;;^UTILITY(U,$J,358.3,49007,2)
 ;;=^5063261
 ;;^UTILITY(U,$J,358.3,49008,0)
 ;;=Z72.53^^185^2428^62
 ;;^UTILITY(U,$J,358.3,49008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49008,1,3,0)
 ;;=3^High Risk Bisexual Behavior
 ;;^UTILITY(U,$J,358.3,49008,1,4,0)
 ;;=4^Z72.53
 ;;^UTILITY(U,$J,358.3,49008,2)
 ;;=^5063260
 ;;^UTILITY(U,$J,358.3,49009,0)
 ;;=Z72.51^^185^2428^63
 ;;^UTILITY(U,$J,358.3,49009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49009,1,3,0)
 ;;=3^High Risk Heterosexual Behavior
 ;;^UTILITY(U,$J,358.3,49009,1,4,0)
 ;;=4^Z72.51
 ;;^UTILITY(U,$J,358.3,49009,2)
 ;;=^5063258
 ;;^UTILITY(U,$J,358.3,49010,0)
 ;;=Z72.52^^185^2428^64
 ;;^UTILITY(U,$J,358.3,49010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49010,1,3,0)
 ;;=3^High Risk Homosexual Behavior
